OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Signaling pathways in cancer metabolism: mechanisms and therapeutic targets
Mengshu You, Zhuolin Xie, Nan Zhang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 118

Showing 1-25 of 118 citing articles:

Multifaceted role of mTOR (mammalian target of rapamycin) signaling pathway in human health and disease
Vivek Panwar, Aishwarya Singh, Manini Bhatt, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 304

Drug resistance in ovarian cancer: from mechanism to clinical trial
Ling Wang, Xin Wang, Xueping Zhu, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 44

Mechanism insights and therapeutic intervention of tumor metastasis: latest developments and perspectives
Xiaoli Shi, Xinyi Wang, Wentao Yao, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 29

Metabolic reprogramming in tumor immune microenvironment: Impact on immune cell function and therapeutic implications
Yuqiang Liu, Yu Zhao, Huisheng Song, et al.
Cancer Letters (2024) Vol. 597, pp. 217076-217076
Open Access | Times Cited: 16

Energy metabolism in health and diseases
Hui Liu, Shuo Wang, Jianhua Wang, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 5

ALDH and cancer stem cells: Pathways, challenges, and future directions in targeted therapy
Kousalya Lavudi, Shreya Madhav Nuguri, Prashant Pandey, et al.
Life Sciences (2024) Vol. 356, pp. 123033-123033
Closed Access | Times Cited: 14

Cancer immunometabolism: advent, challenges, and perspective
Qin Dang, Borui Li, Bing Jin, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 13

Lipid metabolism and its implications in tumor cell plasticity and drug resistance: what we learned thus far?
Ravichandran Vishwa, Bandari BharathwajChetty, Sosmitha Girisa, et al.
Cancer and Metastasis Reviews (2024) Vol. 43, Iss. 1, pp. 293-319
Open Access | Times Cited: 12

Energy metabolism as the hub of advanced non-small cell lung cancer management: a comprehensive view in the framework of predictive, preventive, and personalized medicine
Ousman Bajinka, Serge Yannick Ouédraogo, Olga Golubnitschaja, et al.
The EPMA Journal (2024) Vol. 15, Iss. 2, pp. 289-319
Open Access | Times Cited: 10

A mechanistic insight into the anticancer potentials of resveratrol: Current perspectives
Md. Shimul Bhuia, Raihan Chowdhury, Mst. Asma Akter, et al.
Phytotherapy Research (2024) Vol. 38, Iss. 8, pp. 3877-3898
Closed Access | Times Cited: 10

Uveal Melanoma: Comprehensive Review of Its Pathophysiology, Diagnosis, Treatment, and Future Perspectives
Merve Kulbay, Emily Marcotte, Raheem Remtulla, et al.
Biomedicines (2024) Vol. 12, Iss. 8, pp. 1758-1758
Open Access | Times Cited: 6

Ketogenic diet reshapes cancer metabolism through lysine β-hydroxybutyrylation
Junhong Qin, Xinhe Huang, Shengsong Gou, et al.
Nature Metabolism (2024) Vol. 6, Iss. 8, pp. 1505-1528
Closed Access | Times Cited: 6

Intelligent Delivery Systems in Tumor Metabolism Regulation: Exploring the Path Ahead
Xu‐Wen Li, Tao Sun, Chen Jiang
Advanced Materials (2023) Vol. 36, Iss. 11
Closed Access | Times Cited: 14

Comprehensive scientometrics and visualization study profiles lymphoma metabolism and identifies its significant research signatures
Song‐Bin Guo, Danqi Pan, Ning Su, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 13

Mechanisms and technologies in cancer epigenetics
Zaki A. Sherif, Olorunseun O. Ogunwobi, Habtom W. Ressom
Frontiers in Oncology (2025) Vol. 14
Open Access

A Narrative Review of Prognostic Gene Signatures in Oral Squamous Cell Carcinoma Using LASSO Cox Regression
Nur Fatinazwa Mohd Faizal, Saptarsi Shai, Bansi Savaliya, et al.
Biomedicines (2025) Vol. 13, Iss. 1, pp. 134-134
Open Access

FASN inhibition shows the potential for enhancing radiotherapy outcomes by targeting glycolysis, AKT, and ERK pathways in breast cancer
Ching-I Chen, Deng-Yu Kuo, Hui-Yen Chuang
International Journal of Radiation Biology (2025), pp. 1-12
Open Access

CRYAB is upregulated and predicts clinical prognosis in kidney renal clear cell carcinoma
Hao Ren, Xinyu Chen, Meiling Ji, et al.
IUBMB Life (2025) Vol. 77, Iss. 1
Closed Access

Functional genomics pipeline identifies CRL4 inhibition for the treatment of ovarian cancer
Sally E. Claridge, Shalini Nath, Andrew Baum, et al.
Clinical and Translational Medicine (2025) Vol. 15, Iss. 2
Open Access

Long-chain acylcarnitine deficiency promotes hepatocarcinogenesis
Kaifeng Wang, Zhixian Lan, Heqi Zhou, et al.
Acta Pharmaceutica Sinica B (2025)
Open Access

Page 1 - Next Page

Scroll to top